Biomarkers for coronary artery disease: mission impossible?
High-sensitive cardiac troponin assays: application for prime-time use
A sensitive troponin I method for early diagnosis of acute myocardial infarction
Using sensitive cardiac troponin methods for early diagnosis of acute myocardial infarction
Company Profile: Aterovax
Endothelial function as a functional expression of cardiovascular risk factors
Biomarkers of inflammation and oxidative stress in atherosclerosis
Biomarkers of vulnerable plaque: the missing link with ischemia
A timely diagnosis of myocardial infarction
Clinical application of sensitive cardiac troponin assays: potential and limitations
Predicting the no-reflow phenomenon following successful percutaneous coronary intervention
Residual platelet reactivity: predicting short- and long-term clinical outcome in patients undergoing percutaneous coronary revascularization
The dire need to develop a clinically validated screening method for the detection of early-stage ovarian cancer
Novel approach for identifying smokers at highest risk for developing lung cancer
First steps towards a urinary test for colorectal cancer
EGF receptor shows potential as an early marker of breast cancer
DNA swings into action with the new ‘switchSENSE’ chip for protein analysis
A potential nano-bio-chip for rapid detection of oral cancer is developed
Serum resistin: physiology, pathophysiology and implications for heart failure
The fatal attraction between pro-prion and filamin A: prion as a marker in human cancers
Biomarker use in tailored combat casualty care
Recommendations to qualify biomarker candidates of drug-induced liver injury
Acknowledgements